Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NINA ZILBERMAN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1265541015
CMS profile
329988
Location
REGO PARK, NY

General Payments · PY2018–2024

$2,110.94

  • Reported across 75 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$334.28

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $334.28 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $122.30 6
Acerta Pharma LLC $104.80 5
Novo Nordisk AS $84.36 3
ITI, Inc. $22.82 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $209.13 3
PY2019 $211.67 4
PY2020 $102.73 6
PY2021 $430.34 24
PY2022 $226.87 11
PY2023 $595.92 12
PY2024 $334.28 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.46 02/08/2024 Food and Beverage Undisputed 01/23/2026 1106398191 CMS
ABBVIE INC. $27.01 03/20/2024 Food and Beverage Undisputed 01/23/2026 1106398193 CMS
ABBVIE INC. $16.81 04/04/2024 Food and Beverage Undisputed 01/23/2026 1106398195 CMS
ABBVIE INC. $20.83 05/07/2024 Food and Beverage Undisputed 01/23/2026 1106398197 CMS
ABBVIE INC. $17.73 05/22/2024 Food and Beverage Undisputed 01/23/2026 1106398199 CMS
ABBVIE INC. $13.46 06/18/2024 Food and Beverage Undisputed 01/23/2026 1106398201 CMS
AstraZeneca Pharmaceuticals LP $20.00 02/06/2024 Food and Beverage Undisputed 01/23/2026 1104279041 CMS
AstraZeneca Pharmaceuticals LP $22.50 04/09/2024 Food and Beverage Undisputed 01/23/2026 1105758855 CMS
AstraZeneca Pharmaceuticals LP $22.39 06/18/2024 Food and Beverage Undisputed 01/23/2026 1105616885 CMS
AstraZeneca Pharmaceuticals LP $20.61 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105496949 CMS
AstraZeneca Pharmaceuticals LP $19.30 11/07/2024 Food and Beverage Undisputed 01/23/2026 1104420243 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.82 12/19/2024 Food and Beverage Undisputed 01/23/2026 1143349856 CMS
Novo Nordisk Inc $25.00 05/30/2024 Food and Beverage Undisputed 01/23/2026 1096963147 CMS
Novo Nordisk Inc $25.00 08/22/2024 Food and Beverage Undisputed 01/23/2026 1096856057 CMS
Novo Nordisk Inc $34.36 10/25/2024 Food and Beverage Undisputed 01/23/2026 1097314721 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.